Inside Eli Lilly's $1.2 Billion Deal with Ventyx Biosciences
Eli Lilly Purchases Ventyx Biosciences for $1.2 billion. Ventyx Biosciences is advancing a gallimaufry of treatments. Including but not limited to, oral therapies for inflammatory bowel diseases. Thank you for listening. Visit myoddman.com and subscribe for more! Super News #122.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.